137 related articles for article (PubMed ID: 24709584)
1. Contralateral axillary nodal involvement from invasive breast cancer.
Kiluk JV; Prowler V; Lee MC; Khakpour N; Laronga C; Cox CE
Breast; 2014 Jun; 23(3):291-4. PubMed ID: 24709584
[TBL] [Abstract][Full Text] [Related]
2. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
[TBL] [Abstract][Full Text] [Related]
3. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
4. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
[TBL] [Abstract][Full Text] [Related]
5. Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
Chkheidze R; Sanders MAG; Haley B; Leitch AM; Sahoo S
Clin Breast Cancer; 2018 Aug; 18(4):298-304. PubMed ID: 29233470
[TBL] [Abstract][Full Text] [Related]
6. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted?
Trisal V; Qian D; Wagman LD
Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841
[TBL] [Abstract][Full Text] [Related]
7. Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S339-42. PubMed ID: 19777181
[TBL] [Abstract][Full Text] [Related]
8. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcome of secondary axillary dissection in breast cancer patients with axillary nodal relapse.
Shen SC; Liao CH; Lo YF; Tsai HP; Kuo WL; Yu CC; Chao TC; Chen MF; Chang HK; Lin YC; Shen WC; Ueng SH; Lee LY; Hsueh S; Huang YT; Chen SC
Ann Surg Oncol; 2012 Apr; 19(4):1122-8. PubMed ID: 21969085
[TBL] [Abstract][Full Text] [Related]
13. Altered lymphatic drainage after breast-conserving surgery and axillary node dissection: local recurrence with contralateral intramammary nodal metastases.
Wellner R; Dave J; Kim U; Menes TS
Clin Breast Cancer; 2007 Feb; 7(6):486-8. PubMed ID: 17386126
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
[TBL] [Abstract][Full Text] [Related]
15. Ipsilateral nodal recurrence after axillary dissection for breast cancer.
Walsh N; Kiluk JV; Sun W; Khakpour N; Laronga C; Lee MC
J Surg Res; 2012 Sep; 177(1):81-6. PubMed ID: 22498028
[TBL] [Abstract][Full Text] [Related]
16. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
17. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
18. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer.
Voogd AC; Cranenbroek S; de Boer R; Roumen RM; Rutten HJ; van der Sangen MJ
Eur J Surg Oncol; 2005 Jun; 31(5):485-9. PubMed ID: 15922883
[TBL] [Abstract][Full Text] [Related]
20. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
